Navigation Links
Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
Date:8/4/2009

e Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and its Quarterly Report on Form 10-Q for the period ended June 30, 2009, which will be filed with the SEC on or about August 7, 2009. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2009 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.

                          Poniard Pharmaceuticals, Inc.
                 Condensed Consolidated Statements of Operations
                      (In thousands, except per share data)
                                   (Unaudited)

                                          Three Months      Six Months Ended
                                         Ended June 30,         June 30,
                                       -----------------   -----------------
                                          2009      2008      2009      2008
                                          -
'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
2. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
3. Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
4. Poniard Pharmaceuticals Files Shelf Registration
5. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
6. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
7. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
8. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
9. Poniard Pharmaceuticals Reschedules Fourth Quarter and Fiscal 2008 Results Conference Call for Monday, March 16
10. Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12
11. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... OncLive® is pleased to announce ... its Strategic Alliance Partnership program. , By ... Lineberger will have the opportunity to work with ... cutting-edge research initiatives, community-directed cancer prevention programs, and ... with OncLive to educate their peers by providing ...
(Date:7/23/2014)... Boston, MA (PRWEB) July 23, 2014 ... regenerative medicine transplant therapies are biological, but not ... trials may seem to treat them as if ... as well as unsanctioned studies that constitute “stem ... transplantation as an approach to developing new regenerative ...
(Date:7/22/2014)... Web) July 21, 2014 (PRWEB) July 23, 2014 ... Biomaterials, at Rutgers University. , The goal ... ideas across the full spectrum of scientists working ... research and development topics that represent the most ... been programmed to:,     Provide faculty ...
(Date:7/22/2014)... 22, 2014 Even within a phylum so full of ... among other arthropods for its cruelty -- at least to ... the fly is a most predatory sort of parasite. It ... a smear of larvae, and leaves its wicked brood to ... , None of this would be possible without the fly,s ...
Breaking Biology Technology:OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4
... BELMONT, Calif., March 5, 2012  Phalanx Biotech Group, ... the OneArray® line of open-platform microarrays for whole ... several new product launches in 2011, Phalanx Biotech ... markets.  "2011 proved to be a very busy ...
... scientists at the U.S. Department of Energy,s Lawrence Berkeley National ... of gold mere nanometers (billionths of a meter) thick were ... to cool. They watched in surprise as peculiar features expanded ... settling into circles surrounded by irregular blisters. The ...
... an earthquake and tsunami hit Japan on March ... country,s failures in disaster planning and crisis management for ... The article, out now in the Bulletin of ... agencies were thoroughly unprepared for the cascading nuclear disaster, ...
Cached Biology Technology:Phalanx Biotech Group Reports Robust Revenue Growth in 2011 2Solved: The mystery of the nanoscale crop circles 2Solved: The mystery of the nanoscale crop circles 3Solved: The mystery of the nanoscale crop circles 4Fukushima 1 year on: Poor planning hampered Fukushima response 2Fukushima 1 year on: Poor planning hampered Fukushima response 3
(Date:7/23/2014)... -- BCC Research ( www.bccresearch.com ... AND TECHNOLOGIES FOR SENSORS , the global market for ... nearly $154.4 billion by 2020, with a five-year compound ... and level sensors segment is moving at a significant ... , Sensors have become indispensable to many ...
(Date:7/23/2014)... news release is available in German . ... varying sensory modalities for orientation, some of which might ... example take the polarization pattern produced by sunlight in ... from the Max Planck Institute for Ornithology in Seewiesen, ... from Israel that a night active mammal, the greater ...
(Date:7/23/2014)... are packed with healthful compounds, and now lab tests ... as prescription anti-diabetic medication, scientists report. In their new ... Food Chemistry , they found that how the herbs ... which compounds contribute the most to this promising trait. ... that in 2012, type-2 diabetes affected more than 8 ...
Breaking Biology News(10 mins):Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3Bats use the evening sky's polarization pattern for orientation 2
... papers appearing in the prestigioous journal Science ... Besansky, a professor of biological sciences and a member ... University of Notre Dame, provided evidence that Anopheles gambiae, ... the malaria parasite in Sub-Saharan Africa, is evolving into ...
... a mouse that can run on a treadmill twice ... supply of acetylcholine, the neurotransmitter essential for muscle contraction., ... could lead to new treatments for neuromuscular disorders such ... fail to reach the muscles, said Randy Blakely, Ph.D., ...
... While Yellowstone,s celebrated bison may be among the ... habits and increasing numbers have raised questions about the ... the National Park Service has partnered with Syracuse University ... climate change and herbivores on the park,s grasslands over ...
Cached Biology News:New study examines immunity in emerging species of a major mosquito carrer of malaria 2Boosting supply of key brain chemical reduces fatigue in mice 2SU biologist partners with National Park Service to study bison grazing in Yellowstone 2SU biologist partners with National Park Service to study bison grazing in Yellowstone 3
... cells were cultured in DMEM with 4 mM ... growth. In order to keep the antigens ... acetone-methanol. The cells are arrayed on a ... wells surface specifically treated to enhance cellular attachment ...
... The CopyControl™ vector can be induced prior ... vectors provide the stability of single-copy BACs ... or other cloning vectors. The kits provide ... reagents, insert size screening system) necessary to ...
...
... General description: The "egg crate" style ... any Costar flat bottom strips. Linkage: This ... created to easily match Cornings product number. ... under the old Sigma-Aldrich number (Z71,456-9) or ...
Biology Products: